Clinical trial

Minocycline in Clinically Isolated Syndromes (CIS)

NCT00666887

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE3

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2017-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Clinically Isolated Syndromesunresolved

Early Single Relapse of Multiple Sclerosisunresolved

Interventions

MinocyclineDRUG · verified · RxNorm: minocycline

PlaceboDRUG

Sponsors & collaborators

Dr. Luanne Metzlead sponsor

Multiple Sclerosis Society of Canadacollaborator

Mapped research locations

TorontoOntario, Canada1 MontrealQuebec, Canada1 VancouverBritish Columbia, Canada1 OttawaOntario, Canada1 EdmontonAlberta, Canada1 LondonOntario, Canada1 CalgaryAlberta, Canada1 QuébecQuebec, Canada1 WinnipegManitoba, Canada1 HalifaxNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00666887 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.